Best Medical Stocks To Own Right Now

2016 was a painful year for Illumina’s (NASDAQ:ILMN) investors. Shares of the genomic-sequencing company dropped by more than 29% during the year in response to disappointing quarterly results. Will the company be able to right the ship in 2017? Here are three reasons to believe that the answer is yes.

Image source: Illumina.

New partnerships could open doors

Illumina recently announced that it has joined forces with Royal Philips NV and IBMin an effort to make processing and analyzing genomics data easier. While these deals are still quite new, they promise to open doors and advance the use of genomic testing in ways that Illumina could never do on its own.

I’m particularly excited about the potential of the IBM partnership. Interpreting genetic data is a massively complex undertaking, but IBM’s Watson appears to be up to the challenge. IBM has been investing in Watson for years, and it has become quite adept at pattern recognition. The two companies believe that Watson will be able to quickly comb through thousands of scientific articles, medical books, and clinical trials in order to quickly create standardized reports.

Best Medical Stocks To Own Right Now: Applied Optoelectronics, Inc.(AAOI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Applied Optoelectronics Inc (NASDAQ: AAOI) was down, falling around 19 percent to $47.59 after the company offered a warning related to its upcoming third-quarter results Thursday afternoon. Applied Optoelectronics reduced its third-quarter sales guidance from a prior $107 million-$115 million to a new range of $88 million-$89 million. Earnings per share are expected to come in between $1.04 and $1.09, well below the previous guidance figures in the range of $1.30-$1.43. The company announced Thursday afternoon its largest customer, Amazon.com, Inc., is no longer placing orders to buy its components.

  • [By Dan Caplinger]

    The stock market mounted a last-minute rally to keep its string of winning days alive, as all three major market benchmarks recovered from losses during most of the day to close higher. The performance again showed the complete confidence that investors seem to have in the market’s longer-term future, despite the fact that some believe that stocks have generally risen too quickly and have been hoping for a pullback. Enough investors seem to be waiting for an opportunity to buy that losses have generally been muted and short-lived. Moreover, some good news sent many individual stocks higher, and Nordstrom (NYSE:JWN), RH (NYSE:RH), and Applied Optoelectronics (NASDAQ:AAOI) were among the top performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Peter Graham]

    Small cap fiber-optic networking product Applied Optoelectronics (NASDAQ: AAOI), a potential peer of EMCORE Corporation (NASDAQ: EMKR), Finisar Corporation (NASDAQ: FNSR) and Oclaro Inc (NASDAQ: OCLR), is thefifth mostshorted stock on theNASDAQ with short interest of 47.69% according to Highshortnterest.com.

Best Medical Stocks To Own Right Now: MGIC Investment Corporation(MTG)

Advisors’ Opinion:

  • [By Brian Feroldi, Chuck Saletta, Tyler Crowe, Jason Hall, and Jordan Wathen]

    With that in mind, we asked a team of Fools each to highlight a stock that a billionaire investor has been selling recently. Read on to see why they chose Cheniere Energy (NYSEMKT:LNG), Activision Blizzard (NASDAQ:ATVI), Suncor Energy (NYSE:SU), MGIC Investment Corporation (NYSE:MTG), and Extended Stay America (NYSE:STAY).

Best Medical Stocks To Own Right Now: EPR Properties(EPR)

Advisors’ Opinion:

  • [By Laurie Kulikowski]

    EPR’s investment pipeline should drive about 6-7% earnings growth in 2016, and historically the company’s dividend growth has roughly equated to earnings growth. Starting with an above-average 6.5% yield, we find this compelling for income-oriented investors. 

  • [By Laurie Kulikowski]

    The company, on the basis of net income growth from the same quarter one year ago, has significantly outperformed against the S&P 500 and exceeded that of the Real Estate Investment Trusts (REITs) industry average. The net income increased by 17.5% when compared to the same quarter one year prior, going from $42.71 million to $50.20 million.

     

  • [By Laurie Kulikowski]

    EPR PROPERTIES has improved earnings per share by 11.8% in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, EPR PROPERTIES reported lower earnings of $2.78 versus $3.13 in the prior year. This year, the market expects an improvement in earnings ($2.91 versus $2.78).

     

  • [By Laurie Kulikowski]

    We rate EPR PROPERTIES as a Buy with a ratings score of B. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company’s strengths can be seen in multiple areas, such as its revenue growth, increase in net income, good cash flow from operations, expanding profit margins and growth in earnings per share. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. 

  • [By Laurie Kulikowski]

    EPR’s revenue growth has slightly outpaced the industry average of 6.1%. Since the same quarter one year prior, revenues slightly increased by 9.7%. This growth in revenue appears to have trickled down to the company’s bottom line, improving the earnings per share.

     

Best Medical Stocks To Own Right Now: JAKKS Pacific, Inc.(JAKK)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Hasbro, Inc largely trending upward while shares of peers like mid cap Mattel, Inc (NASDAQ: MAT) and small cap JAKKS Pacific, Inc (NASDAQ: JAKK) have largely trended downward:

  • [By Roberto Pedone]

    One under-$10 toy player that’s trending very close to triggering a major breakout trade is Jakks Pacific (JAKK), which is a producer and marketer of children’s toys and other consumer products. This stock has been destroyed by the bears so far in 2013, with shares off sharply by 60%.

    If you take a look at the chart for Jakks Pacific, you’ll notice that this stock has been downtrending badly for the last two months and change, with shares plunging from its high of $11.75 to its recent low of $4.82 a share. During that downtrend, shares of JAKK have been consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of JAKK look like they might be ready to see an end to its downside volatility in the short-term if the recent lows can hold. I believe this due to the fact that JAKK has started to move sideways and trend within range of triggering a major breakout trade.

    Traders should now look for long-biased trades in JAKK if it manages to break out above some near-term overhead resistance levels at $5.08 to $5.27 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 695,817 shares. If that breakout triggers soon, then JAKK will set up to re-test or possibly take out its next major overhead resistance levels at $5.68 to its 50-day moving average at $6.07 a share. Any high-volume move above its 50-day will then put $7 to $8 into range for shares of JAKK.

    Traders can look to buy JAKK off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $4.87 to $4.82 a share. One can also buy JAKK off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  • [By Peter Graham]

    A long term performance chart shows shares of Hasbro, Inc largely going in one direction while shares of peers likemid cap Mattel, Inc (NASDAQ: MAT)and small cap JAKKS Pacific, Inc (NASDAQ: JAKK) have gone in the other direction:

Best Medical Stocks To Own Right Now: Adient plc (ADNT)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Western Digital (WDC) , Twilio (TWLO) , Adient (ADNT) , Salesforce.com (CRM) , AT&T (T) and Verizon (VZ) .

Best Medical Stocks To Own Right Now: U.S. Bancorp(USB)

Advisors’ Opinion:

  • [By Sarfaraz Khan]

    In addition to this, Warren Buffett has also built sizable positions in a number of major US banks.Wells Fargo (NYSE:WFC), U.S. Bancorp (NYSE:USB)and Goldman Sachs (NYSE:GS)have the leading positions in Berkshire Hathaways portfolio. In fact, Wells Fargo is Berkshire Hathaway’s second largest stock holding. In addition to this, Berkshire Hathaway also owns $5 billion worth of Bank of Americas preferred shares and warrants to buy 700 million of the banks ordinary shares at just $7.14 (current price $22.10) anytime until September 2021. These banks are positioned to become the biggest beneficiaries of the increase in interest rates. To get an idea of how this might happen, consider Bank of Americas forecast in which it predicted a $7.5 billion boost to annual net interest income following a 1-percentage-point increase in interest rates.

  • [By John Maxfield]

    One of this era’s most successful bankers has decided to relinquish the reins. U.S. Bancorp (NYSE:USB) announced on Tuesday that chairman and CEO Richard Davis will step down from his role as CEO at the bank’s annual meeting in April. He’ll stay on as executive chairman of the board, while President and COO Andy Cecere will succeed him in the corner office.

Leave a Reply

Your email address will not be published. Required fields are marked *